De Novo Peptide Sequencing by Deep Learning
-
Feature engineering heavily relies on prior domain knowledge;
-
Capturing contextual dependencies and long-range sequence relationships is challenging;
-
Generalization to non-standard modifications or novel peptide sequences is limited.
-
Integrating deep learning models into workflows for de novo sequencing, antibody sequence reconstruction, and modified peptide identification;
-
Developing a Transformer-based multitask learning platform for peptides, supporting multifunctional property prediction and candidate selection;
-
Collaborating with clients to establish a closed-loop system of “data–model–validation” to enhance the experimental verifiability of computational predictions.
Deep learning, characterized by its ability to automatically extract meaningful features from complex data via deep neural network architectures, has been extensively applied in domains such as image recognition, natural language processing, and bioinformatics. In recent years, it has also been increasingly employed in peptide sequence analysis. Applications range from de novo sequencing and peptide function prediction to antigen epitope identification and MHC binding affinity estimation, consistently demonstrating superior performance compared to traditional algorithms. This paper presents a comprehensive overview of the core methodologies, representative models, and key applications of deep learning in the context of peptide sequence analysis.
Why Choose Deep Learning for Peptide Sequence Analysis?
Conventional approaches to peptide identification and function prediction largely depend on rule-based algorithms or manually engineered features, such as support vector machines (SVM), hidden Markov models (HMM), and scoring matrices. Although these methods are well-established, they encounter several limitations when processing large-scale, high-dimensional, and noisy mass spectrometry (MS) data:
In contrast, deep learning models enable end-to-end training, allowing them to automatically learn latent patterns directly from raw data. This makes them particularly well-suited for analyzing the heterogeneous and complex nature of peptide sequences.
Major Model Architectures and Application Tasks
1. CNN: Convolutional Neural Networks
CNNs are effective at identifying local patterns within peptide sequences and are commonly used in tasks such as MHC binding prediction and antimicrobial peptide classification. Their main advantages include fast training speed and the ability to extract structural features within small receptive fields.
2. RNN/LSTM: Recurrent Neural Networks and Long Short-Term Memory Networks
RNNs and their variants, such as LSTMs, excel at modeling sequential data by capturing contextual dependencies across time steps. They have been widely applied in de novo peptide sequencing and sequence generation. A notable example is DeepNovo, which leverages LSTM-based architectures to integrate spectral data with peptide sequences, enabling accurate de novo peptide-level reconstruction.
3. Transformer: Attention-Based Models
Transformers, distinguished by their attention mechanisms and parallel computation capabilities, have emerged as a transformative architecture for modeling protein and peptide sequences. Noteworthy applications include AlphaPeptDeep, which utilizes a Transformer backbone to interpret MS/MS spectra with significantly enhanced accuracy, and ProGen2, designed to generate native-like peptide sequences, thereby advancing the development of synthetic proteins.
4. Multimodal Models
Multimodal deep learning models integrate mass spectrometry data (e.g., spectra or images) with sequence-based textual data to perform joint learning. This holistic approach facilitates unified tasks such as peptide identification, structural inference, and functional annotation within a single framework.
Core Applications Driven by Deep Learning
1. De Novo Peptide Sequencing
Traditional algorithms are often constrained by the complexity of fragmentation spectra and the limitations of heuristic scoring strategies, which hampers their ability to accurately identify medium to long peptides or locate post-translational modifications. Deep learning models, such as DeepNovo and pDeep, trained in an end-to-end manner, have consistently outperformed conventional methods in terms of accuracy, recall, and processing speed. At MtoZ Biolabs, we have integrated DeepNovo2 and a proprietary lightweight Transformer-based model into our de novo sequencing workflow, resulting in over a 10% improvement in peptide prediction accuracy. This enhanced pipeline is widely applied in antibody sequencing and the analysis of unknown proteins.
2. Screening of Antimicrobial and Functional Peptides
Deep learning-based tools such as AMPScanner and AI4AMP enable rapid identification of potential bioactive peptides, including antimicrobial, antiviral, and immunomodulatory peptides. These models significantly shorten the experimental screening cycle and accelerate the development of next-generation peptide therapeutics.
3. MHC-I/II Binding Prediction and T Cell Epitope Identification
Deep learning models like NetMHCpan, MHCflurry 2.0, and TransPHLA have achieved predictive performance approaching that of experimental assays in estimating the binding affinity between peptides and MHC molecules. These advances are increasingly being translated into practical applications such as personalized cancer vaccine design and tumor neoantigen discovery.
MtoZ Biolabs “AI Empowering Proteomics” Strategy
From sequence identification to functional annotation, from structural modeling to drug discovery, deep learning is reshaping the landscape of proteomics research and applications at an unprecedented pace. For researchers, proficiency in AI-driven tools is rapidly becoming an essential competency in the evolving field of bioinformatics.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
